Skip to main content
Clinical Trials/NCT02252861
NCT02252861
Completed
Not Applicable

French Database of Left Atrial Appendage Closure

Henri Mondor University Hospital1 site in 1 country840 target enrollmentOctober 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation and Other Dysrhythmias | Patient
Sponsor
Henri Mondor University Hospital
Enrollment
840
Locations
1
Primary Endpoint
Assessment of the rate of thromboembolic events related to atrial fibrillation in patients treated by left atrial appendage closure in daily practice in France
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Patients with atrial fibrillation are exposed to a high risk of thrombus in the left atrium that can induce cerebral vascular events or systemic embolisms. This justifies the prescription of anticoagulant therapies in patients with high risk of thromboembolic event. Percutaneous left atrial appendage closure is a new interventional strategy for patients with high risk of cardiovascular events and a counter-indication for long term treatment with anticoagulant agents. However, only few data are available on effectiveness and prognosis of patients treated by this new interventional strategy.

This national database record per-procedure and follow-up data of patients treated by left atrial appendage closure.

This database is strictly observational.

Percutaneous left atrial appendage closure is performed only for the purpose of patient care. No specific intervention is performed specifically for the database. Neither left atrial appendage closure procedure nor patient follow up are modified by patient inclusion in the database.

Registry
clinicaltrials.gov
Start Date
October 2013
End Date
September 2018
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Henri Mondor University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Philippe Le Corvoisier

MD

Henri Mondor University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients referred to a french interventional cardiology department for percutaneous left atrial appendage closure in routine care
  • Signature of an inform consent form for inclusion of data recorded during care in the database

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Assessment of the rate of thromboembolic events related to atrial fibrillation in patients treated by left atrial appendage closure in daily practice in France

Time Frame: 1 year

Secondary Outcomes

  • Unexplained Death rate after left atrial appendage closure(1 year)
  • Cost of patient follow-up after left atrial appendage closure(1 year)
  • Assessment of patient management in daily practice after left atrial appendage closure (number of echocardiography procedures)(1 year)
  • Death rate from cardiovascular disease after left atrial appendage closure(1 year)
  • Adverse events related to the procedure(1 year)
  • Cost of the procedure of left atrial appendage closure(Costs will be assessed for the duration of hospital stay, an expected average of 3 days)
  • Assessment of patient medical treatment in daily practice after left atrial appendage closure (percentage of patients with antiplatelet drugs)(1 year)

Study Sites (1)

Loading locations...

Similar Trials